Latest News
- Physician-scientist recognized as a thought leader in cancer genomics and immunotherapy
Dr. Antoni Ribas, a renowned physician-scientist and professor of medicine in the David Geffen School of Medicine at UCLA, was selected by Agilent Technologies for their prestigious Thought Leader Award.
April 17, 2019 8:00 AM
detail - Artificial intelligence performs as well as experienced radiologists in detecting prostate cancer
UCLA researchers have developed a new artificial intelligence system to help radiologists improve their ability to diagnose prostate cancer.
April 16, 2019 6:00 AM
detail - Recently identified gene mutation which predicts increased risk of cancers has profound effect on normal breast cells
In a study published online in Springer Nature, UCLA researchers have proven the impact of a new class of gene mutations on normal cellular biology.
April 15, 2019 8:00 AM
detail - UCLA researchers study cost-effectiveness of rectal cancer treatments
Costs are on the rise for many kinds of medical treatments. UCLA researchers are looking for cost-effective ways to treat people who have locally advanced rectal cancer, a cancer located in the end section of the large intestine.
April 12, 2019 11:00 AM
detail - New study reveals optimal dose of stereotactic body radiation therapy to treat non-small cell lung cancer
In a new study published in the International Journal of Radiation Oncology, Biology, Physics, 160 articles about the usage of stereotactic body radiation or stereotactic ablative radio therapy were evaluated to determine the optimal dose to treat this cancer.
April 09, 2019 9:00 AM
detail - Researchers identify a potential way to treat cancers regardless of their tissue of origin
In a pre-clinical study led by UCLA, scientists discovered that treating a subset of multiple myeloma tumors with therapeutic drugs has the potential to prevent them from progressing.
April 08, 2019 8:00 AM
detail - UCLA’s Antoni Ribas named American Association for Cancer Research President-Elect
Dr. Antoni Ribas has been named the 2019-2020 President-Elect for the American Association for Cancer Research.
March 28, 2019 8:00 AM
detail - Heating up tumors could make CAR T therapy more effective, study finds
A UCLA-led research team has developed a spray gel embedded with immune-boosting drugs that could help fight recurrent cancer.
March 27, 2019 8:00 AM
detail - Female radiation oncologists submit fewer charges to Medicare, collect less revenue, study finds
A new study by UCLA researchers has found that female radiation oncologists submit fewer charges to Medicare, are reimbursed less per charge submitted and receive lower Medicare payments overall in comparison to male radiation oncologists.
March 22, 2019 9:45 AM
detail - Organic chemist Michael Jung wins American Association for Cancer Research Award
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.
March 21, 2019 4:00 PM
detail - UCLA researchers identify potential new combination treatment for pancreatic cancer
Researchers from UCLA’s Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world’s deadliest cancers.
March 20, 2019 1:00 PM
detail - Giving patients a voice
Dr. Patricia Ganz answers questions about new UCLA-led research to understand treatment tolerability by including the patient’s feedback in cancer research
March 20, 2019 10:00 AM
detail - UCLA researchers to present on latest advancements in immunotherapy and combination therapies at annual AACR meeting
Physicians and scientists from UCLA’s Jonsson Comprehensive Cancer Center will be joining more than 22,500 scientists, clinicians, advocates and industry luminaries from institutions around the world to discuss the most recent advancements in cancer research at the 110th AACR annual meeting.
March 19, 2019 9:00 AM
detail - Physician-scientist selected by gastroenterological association to promote diversity
Dr. Fola May was selected as a 2019–2020 scholar by the American Gastroenterological Association for its new program to help promote diversity in the field of gastroenterology.
February 26, 2019 8:00 AM
detail - Lab-grown mini tumors could help identify personalized treatments for people with rare cancers
UCLA scientists have developed a new method to quickly screen hundreds of drugs in order to identify treatments that can target specific tumors.
February 25, 2019 8:00 AM
detail - Melanoma researcher receives grant from the American Skin Association
Willy Hugo has been awarded the Daneen & Charles Stiefel Investigative Scientist Award for Melanoma Research by the American Skin Association to help further his research in understanding treatment-resistant melanoma
February 25, 2019 8:00 AM
detail - Cancer researcher receives grant to develop new therapies for advanced melanoma
Dr. Roger Lo received a three-year, $600,000 grant from the V Foundation for Cancer Research to help understand and develop new therapies for an aggressive form of melanoma driven by so-called RAS mutations.
February 20, 2019 8:00 AM
detail - For recurrent glioblastoma, immunotherapy before surgery appears to help more than afterward
A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before surgery is more effective than using the drug afterward.
February 11, 2019 6:00 AM
detail - Shorter course of radiation therapy effective in treating men with prostate cancer
A new UCLA-led study shows that men with low- or intermediate-risk prostate cancer can safely undergo higher doses of radiation over a significantly shorter period of time and still have the same, successful outcomes as from a much longer course of treatment.
February 08, 2019 8:00 AM
detail - Newly identified characteristics of prostate tumors could help improve diagnosis and treatment
New research from UCLA, in collaboration with groups in Toronto, published in European Urology identifies a set of characteristics in tumors that determine if they can be seen by Multiparametric Magnetic Resonance Imaging (MRI).
February 07, 2019 6:00 AM
detail